RedHill Biopharma (RDHL) Research Hub

RedHill Biopharma (RDHL) trades on NASDAQ, IL in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 0.4159 USD (-1.72%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.34, market cap 0.00B. This hub links to the full technical, earnings and options research available for RDHL.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Drug Manufacturers - Specialty & Generic)
ExchangeNASDAQ, IL
Last close0.4159 USD (-1.72%)
52-week range0.3901 USD – 0.9429 USD
Trend regimeRange
14-day RSI40.5 (Bearish)
Trailing P/E-0.34
Market cap0.00B
Dividend yield0.00%
Next earnings2026-08-20

Available research for RDHL

Earnings

RDHL earnings date and last-quarter result: next report 2026-08-20, last quarter beat, P/E -0.34. Updated 2026-07-23.

Options: Covered Call

Covered Call on RDHL: how it works, illustrative setup around the real 0.4159 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on RDHL: how it works, illustrative setup around the real 0.4159 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on RDHL: how it works, illustrative setup around the real 0.4159 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

RDHL technical analysis: range, last 0.4159 USD, RSI 40.5, 52w range 0.3901 USD–0.9429 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is RDHL in?

RedHill Biopharma (RDHL) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, IL.

Is RDHL in an uptrend or downtrend?

As of 2026-10-26, RDHL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is RDHL's trailing P/E ratio?

RDHL's trailing P/E is -0.34, with a market cap of 0.00B. See the earnings research page for full valuation detail.

When does RDHL next report earnings?

RDHL is next scheduled to report earnings on 2026-08-20.